Importantly, GATA3 chromosome immunoprecipitation (ChIP) results demonstrated that GATA3-TIMM44 promoter binding in P1 glioma cells was robustly decreased after YME1L silencing or depletion (Figure 6G). The gene discussed is GATA3; the disease is central nervous system cancer.